Patrick Forde

Associate Professor

20112020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Patrick Forde is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors

Naing, A., Gainor, J. F., Gelderblom, H., Forde, P. M., Butler, M. O., Lin, C. C., Sharma, S., Ochoa De Olza, M., Varga, A., Taylor, M., Schellens, J. H. M., Wu, H., Sun, H., Silva, A. P., Faris, J., Mataraza, J., Cameron, S. & Bauer, T. M., Mar 15 2020, In : Journal for immunotherapy of cancer. 8, 1, e000530.

Research output: Contribution to journalArticle

Open Access
  • Chronic immune checkpoint inhibitor pneumonitis

    Naidoo, J., Naidoo, J., Lipson, E., Lipson, E. J., Lipson, E. J., Forde, P. M., Forde, P. M., Illei, P. B., Yarmus, L. B., Voong, K. R., Feller-Kopman, D., Lee, H., Riemer, J., Wang, D., Taube, J. M., Brahmer, J. R., Suresh, K., Lin, C. T., Danoff, S. K., D'Alessio, F. R. & 1 others, Suresh, K., Jun 17 2020, In : Journal for immunotherapy of cancer. 8, 1, e000840.

    Research output: Contribution to journalArticle

    Open Access
  • Compartmental analysis of T-Cell clonal dynamics as a function of pathologic response to neoadjuvant PD-1 blockade in resectable non-small cell lung cancer

    Zhang, J., Ji, Z., Caushi, J. X., El Asmar, M., Anagnostou, V., Cottrell, T. R., Chan, H. Y., Suri, P., Guo, H., Merghoub, T., Chaft, J. E., Reuss, J. E., Tam, A. J., Blosser, R. L., Abu-Akeel, M., Sidhom, J. W., Zhao, N., Ha, J. S., Jones, D. R., Marrone, K. A. & 11 others, Naidoo, J., Gabrielson, E., Taube, J. M., Velculescu, V. E., Brahmer, J. R., Housseau, F., Hellmann, M. D., Forde, P. M., Pardoll, D. M., Ji, H. & Smith, K. N., Mar 15 2020, In : Clinical Cancer Research. 26, 6, p. 1327-1337 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction Nomogram

    Friedes, C., Mai, N., Hazell, S., Fu, W., Han, P., Bowers, M., Levy, B., Forde, P., Voong, R. & Hales, R. K., 2020, (Accepted/In press) In : Clinical lung cancer.

    Research output: Contribution to journalArticle

    Open Access
  • Epigenetic therapy inhibits metastases by disrupting premetastatic niches

    Lu, Z., Zou, J., Li, S., Topper, M. J., Tao, Y., Zhang, H., Jiao, X., Xie, W., Kong, X., Vaz, M., Li, H., Cai, Y., Xia, L., Huang, P., Rodgers, K., Lee, B., Riemer, J. B., Day, C. P., Yen, R. W. C., Cui, Y. & 28 others, Wang, Y., Wang, Y., Zhang, W., Easwaran, H., Hulbert, A., Kim, K. B., Juergens, R. A., Yang, S. C., Battafarano, R. J., Bush, E. L., Broderick, S. R., Cattaneo, S. M., Brahmer, J. R., Rudin, C. M., Wrangle, J., Mei, Y., Kim, Y. J., Zhang, B., Wang, K. K. H., Forde, P. M., Margolick, J. B., Nelkin, B. D., Zahnow, C. A., Pardoll, D. M., Housseau, F., Baylin, S. B., Shen, L. & Brock, M. V., Mar 12 2020, In : Nature. 579, 7798, p. 284-290 7 p.

    Research output: Contribution to journalArticle